These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33029806)

  • 21. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
    Schneider R; Sauvant C; Betz B; Otremba M; Fischer D; Holzinger H; Wanner C; Galle J; Gekle M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1599-605. PubMed ID: 17244891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.
    Fenton C; Keating GM; Scott LJ
    Drugs; 2003; 63(19):2013-26; discussion 2027-8. PubMed ID: 12962518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide.
    Shoaf SE; Bramer SL; Bricmont P; Zimmer CA
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):213-22. PubMed ID: 17703139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
    Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
    J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease.
    Hoshino T; Ookawara S; Miyazawa H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Yoshida I; Tabei K
    Clin Exp Nephrol; 2015 Apr; 19(2):247-53. PubMed ID: 24821289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
    Sica D; Gradman AH; Lederballe O; Kolloch RE; Zhang J; Keefe DL
    Clin Drug Investig; 2011 Dec; 31(12):825-37. PubMed ID: 22035463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
    White WB; Calhoun DA; Samuel R; Taylor AA; Zappe DH; Purkayastha D
    J Clin Hypertens (Greenwich); 2008 Jun; 10(6):450-8. PubMed ID: 18550935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial differences in response to acute dosing with hydrochlorothiazide.
    Ripley E; King K; Sica DA
    Am J Hypertens; 2000 Feb; 13(2):157-64. PubMed ID: 10701815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney.
    Wood CE; Cousins R; Zhang D; Keller-Wood M
    Exp Biol Med (Maywood); 2005 Oct; 230(9):668-73. PubMed ID: 16179735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension.
    Tu W; Decker BS; He Z; Erdel BL; Eckert GJ; Hellman RN; Murray MD; Oates JA; Pratt JH
    J Gen Intern Med; 2016 Jan; 31(1):30-6. PubMed ID: 26194642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of organic anion transporter 1 protein is induced by chronic furosemide or hydrochlorothiazide infusion in rat kidney.
    Kim GH; Na KY; Kim SY; Joo KW; Oh YK; Chae SW; Endou H; Han JS
    Nephrol Dial Transplant; 2003 Aug; 18(8):1505-11. PubMed ID: 12897087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
    Karara AH; Hanes V; Alonso A; Ni P; Poola N; Silang R; Blode H; Preston RA
    J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
    Keating GM
    Drugs; 2009 Jun; 69(9):1239-65. PubMed ID: 19537840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
    Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
    Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
    Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
    J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
    Plosker GL; White WB
    Drugs; 2008; 68(13):1877-99. PubMed ID: 18729541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.